Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

AI physician leader

Newswatch: AI-eager doctors, AI-reticent buyers, AI cost worriers, more

In medicine’s next chapter, AI literacy will separate physician leaders from peer followers. 

Vintage neon drug sign at the Walgreens pharmacy on Canal Street in downtown New Orleans.

Walgreens settles DOJ opioid crisis case for $300M

The pharmacy chain was accused of filling “millions” of unlawful prescriptions for opioids and other controlled substances. Despite agreeing to the payout, the company does not admit wrongdoing.

artificial intelligence AI in healthcare news

AI newswatch: Lifecyle AI oversight, data matters, AI vs. animals, more

AI may finally end the paper chase caused by prior authorization. Or it may worsen it. 

UnitedHealth Group - 2

UnitedHealth, Amedisys enter mediation with DOJ over block on $3.3B merger

The two companies have been unable to assuage antitrust concerns raised by the Department of Justice. A magistrate will attempt to hammer out acceptable terms for the home healthcare merger at a conference scheduled for August. 

doctor patient human touch

Newswatch: AI researchers weigh in, AI humanizes healthcare, ‘the worst AI will ever be,’ more

Contrary to popular misgivings, AI may be improving the human touch in healthcare. 

Ransomware Cyberattack Data Breach

DaVita kidney care clinics hit by ransomware attack

The company said part of its network has been encrypted. However, it told the Securities and Exchange Commission it is still able to deliver dialysis care to patients. 

healthcare surprise billing statement payment

UnitedHealth garnishing claims to recoup ‘loans’ from Change Healthcare hack

UnitedHealth Group said it is seeking repayment of “interest-free” advances distributed to providers struggling during the shutdown of claims processing caused by the ransomware attack on Change Healthcare. 

Thumbnail

FDA takes first step toward ending animal testing as part of ‘3.0 modernization'

Monoclonal antibody therapies will be the first drugs permitted to take advantage of alternatives, including advanced lab simulations and artificial intelligence. A pilot framework to phase out the decades-long requirement for animal testing will be rolled out in the coming year, the FDA said.